LCNB Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.72M | Buy |
7,923
+491
| +7% | +$109K | 0.58% | 39 |
|
|
2025
Q4 | $1.7M | Sell |
7,432
-50
| -0.7% | -$11.4K | 0.57% | 36 |
|
|
2025
Q3 | $1.73M | Hold |
7,482
| – | – | 0.61% | 35 |
|
|
2025
Q2 | $1.39M | Hold |
7,482
| – | – | 0.49% | 49 |
|
|
2025
Q1 | $1.57M | Buy |
7,482
+183
| +3% | +$35.6K | 0.58% | 43 |
|
|
2024
Q4 | $1.3M | Buy |
7,299
+38
| +0.5% | +$6.99K | 0.47% | 51 |
|
|
2024
Q3 | $1.43M | Hold |
7,261
| – | – | 0.51% | 46 |
|
|
2024
Q2 | $1.25M | Hold |
7,261
| – | – | 0.47% | 48 |
|
|
2024
Q1 | $1.32M | Sell |
7,261
-12
| -0.2% | -$2.07K | 0.48% | 48 |
|
|
2023
Q4 | $1.13M | Buy |
7,273
+53
| +0.7% | +$7.73K | 0.44% | 54 |
|
|
2023
Q3 | $1.08M | Sell |
7,220
-500
| -6% | -$73.4K | 0.48% | 55 |
|
|
2023
Q2 | $1.04M | Buy |
7,720
+175
| +2% | +$25.7K | 0.44% | 61 |
|
|
2023
Q1 | $1.2M | Sell |
7,545
-375
| -5% | -$57.3K | 0.54% | 48 |
|
|
2022
Q4 | $1.28M | Buy |
7,920
+110
| +1% | +$16.9K | 0.59% | 43 |
|
|
2022
Q3 | $1.05M | Hold |
7,810
| – | – | 0.57% | 45 |
|
|
2022
Q2 | $1.2M | Buy |
7,810
+569
| +8% | +$86.9K | 0.62% | 42 |
|
|
2022
Q1 | $1.17M | Buy |
7,241
+992
| +16% | +$144K | 0.55% | 48 |
|
|
2021
Q4 | $846K | Buy |
6,249
+177
| +3% | +$20.9K | 0.39% | 70 |
|
|
2021
Q3 | $655K | Hold |
6,072
| – | – | 0.33% | 78 |
|
|
2021
Q2 | $684K | Hold |
6,072
| – | – | 0.34% | 76 |
|
|
2021
Q1 | $657K | Buy |
6,072
+50
| +0.8% | +$5.35K | 0.36% | 73 |
|
|
2020
Q4 | $645K | Sell |
6,022
-75
| -1% | -$7.21K | 0.37% | 74 |
|
|
2020
Q3 | $534K | Sell |
6,097
-207
| -3% | -$19.5K | 0.35% | 79 |
|
|
2020
Q2 | $619K | Sell |
6,304
-76
| -1% | -$6.69K | 0.42% | 70 |
|
|
2020
Q1 | $486K | Buy |
6,380
+550
| +9% | +$46.8K | 0.38% | 77 |
|
|
2019
Q4 | $516K | Sell |
5,830
-100
| -2% | -$8.3K | 0.31% | 78 |
|
|
2019
Q3 | $449K | Buy |
5,930
+252
| +4% | +$17.3K | 0.29% | 82 |
|
|
2019
Q2 | $413K | Sell |
5,678
-62
| -1% | -$4.87K | 0.29% | 83 |
|
|
2019
Q1 | $463K | Sell |
5,740
-18
| -0.3% | -$1.47K | 0.34% | 78 |
|
|
2018
Q4 | $531K | Buy |
5,758
+11
| +0.2% | +$967 | 0.44% | 65 |
|
|
2018
Q3 | $544K | Sell |
5,747
-180
| -3% | -$17.1K | 0.38% | 75 |
|
|
2018
Q2 | $549K | Buy |
5,927
+309
| +6% | +$30.2K | 0.5% | 59 |
|
|
2018
Q1 | $531K | Buy |
5,618
+10
| +0.2% | +$1.1K | 0.48% | 60 |
|
|
2017
Q4 | $542K | Sell |
5,608
-100
| -2% | -$9.43K | 0.48% | 60 |
|
|
2017
Q3 | $507K | Sell |
5,708
-130
| -2% | -$9.9K | 0.48% | 60 |
|
|
2017
Q2 | $423K | Sell |
5,838
-100
| -2% | -$6.72K | 0.41% | 66 |
|
|
2017
Q1 | $387K | Sell |
5,938
-50
| -0.8% | -$3.14K | 0.37% | 68 |
|
|
2016
Q4 | $375K | Buy |
+5,988
| New | +$366K | 0.37% | 69 |
|
Other funds holding ABBV
VCM
VPM
LCNB Corp's ABBV Position: Q1 2026 in Review
LCNB Corp increased its AbbVie (ABBV) stake by 6.6% in Q1 2026, buying an estimated $109K and bringing the position to 7,923 shares worth $1.72M. The position accounts for 0.58% of the portfolio, ranked #39.
LCNB Corp first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.73M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- LCNB Corp held 7,923 shares of AbbVie worth $1.72M as of Q1 2026.
- LCNB Corp bought 491 AbbVie shares in Q1 2026, an estimated $109K.
- AbbVie made up 0.58% of LCNB Corp's portfolio in Q1 2026, its #39 holding.
- LCNB Corp first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- LCNB Corp's AbbVie position peaked at $1.73M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.